Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Retinoblastoma-binding protein 2 (RBP2) is frequently expressed in neuroendocrine tumors and promotes the neoplastic phenotype.

Maggi EC, Trillo-Tinoco J, Struckhoff AP, Vijayaraghavan J, Del Valle L, Crabtree JS.

Oncogenesis. 2016 Aug 22;5(8):e257. doi: 10.1038/oncsis.2016.58.

2.

Role of heme oxygenase-1 in the pathogenesis and tumorigenicity of Kaposi's sarcoma-associated herpesvirus.

Dai L, Qiao J, Nguyen D, Struckhoff AP, Doyle L, Bonstaff K, Del Valle L, Parsons C, Toole BP, Renne R, Qin Z.

Oncotarget. 2016 Mar 1;7(9):10459-71. doi: 10.18632/oncotarget.7227.

3.

A novel role for p115RhoGEF in regulation of epithelial plasticity.

Kher SS, Struckhoff AP, Alberts AS, Worthylake RA.

PLoS One. 2014 Jan 23;9(1):e85409. doi: 10.1371/journal.pone.0085409. eCollection 2014.

4.

Neurospheres and glial cell cultures: immunocytochemistry for cell phenotyping.

Struckhoff AP, Del Valle L.

Methods Mol Biol. 2013;1078:119-32. doi: 10.1007/978-1-62703-640-5_10.

PMID:
23975825
5.

PDZ-RhoGEF is essential for CXCR4-driven breast tumor cell motility through spatial regulation of RhoA.

Struckhoff AP, Rana MK, Kher SS, Burow ME, Hagan JL, Del Valle L, Worthylake RA.

J Cell Sci. 2013 Oct 1;126(Pt 19):4514-26. doi: 10.1242/jcs.132381. Epub 2013 Jul 18.

6.

Integrin-binding protein nischarin interacts with tumor suppressor liver kinase B1 (LKB1) to regulate cell migration of breast epithelial cells.

Jain P, Baranwal S, Dong S, Struckhoff AP, Worthylake RA, Alahari SK.

J Biol Chem. 2013 May 31;288(22):15495-509. doi: 10.1074/jbc.M112.418103. Epub 2013 Apr 9.

7.

Altered death receptor signaling promotes epithelial-to-mesenchymal transition and acquired chemoresistance.

Antoon JW, Lai R, Struckhoff AP, Nitschke AM, Elliott S, Martin EC, Rhodes LV, Yoon NS, Salvo VA, Shan B, Beckman BS, Nephew KP, Burow ME.

Sci Rep. 2012;2:539. doi: 10.1038/srep00539. Epub 2012 Jul 27.

8.

RhoA can lead the way in tumor cell invasion and metastasis.

Struckhoff AP, Rana MK, Worthylake RA.

Front Biosci (Landmark Ed). 2011 Jan 1;16:1915-26. Review.

PMID:
21196273
9.

Inhibition of p53 sensitizes MCF-7 cells to ceramide treatment.

Struckhoff AP, Patel B, Beckman BS.

Int J Oncol. 2010 Jul;37(1):21-30.

PMID:
20514393
10.

Dynamic regulation of ROCK in tumor cells controls CXCR4-driven adhesion events.

Struckhoff AP, Vitko JR, Rana MK, Davis CT, Foderingham KE, Liu CH, Vanhoy-Rhodes L, Elliot S, Zhu Y, Burow M, Worthylake RA.

J Cell Sci. 2010 Feb 1;123(Pt 3):401-12. doi: 10.1242/jcs.052167. Epub 2010 Jan 5.

11.

Sphingolipids as determinants of apoptosis and chemoresistance in the MCF-7 cell model system.

Meacham WD, Antoon JW, Burow ME, Struckhoff AP, Beckman BS.

Exp Biol Med (Maywood). 2009 Nov;234(11):1253-63. doi: 10.3181/0902-MR-77. Epub 2009 Jun 22. Review.

PMID:
19546354
12.

Xenobiotic-induced TNF-alpha expression and apoptosis through the p38 MAPK signaling pathway.

Frigo DE, Vigh KA, Struckhoff AP, Elliott S, Beckman BS, Burow ME, McLachlan JA.

Toxicol Lett. 2005 Feb 15;155(2):227-38.

PMID:
15603917
13.

Novel ceramide analogs as potential chemotherapeutic agents in breast cancer.

Struckhoff AP, Bittman R, Burow ME, Clejan S, Elliott S, Hammond T, Tang Y, Beckman BS.

J Pharmacol Exp Ther. 2004 May;309(2):523-32. Epub 2004 Jan 23.

PMID:
14742741

Supplemental Content

Loading ...
Support Center